Co-Diagnostics, Inc.
CODX
$0.3462
$0.00220.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.72% | 19.10% | 24.84% | -62.09% | 14.79% |
| Total Depreciation and Amortization | -13.86% | -15.18% | 14.13% | 18.53% | 10.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.33% | -117.35% | -91.52% | 266.23% | 911.61% |
| Change in Net Operating Assets | -480.43% | -155.73% | 48.48% | 174.89% | -89.20% |
| Cash from Operations | -59.25% | -3.00% | -72.25% | -25.40% | 7.41% |
| Capital Expenditure | -306.80% | 77.16% | 84.29% | 26.29% | 79.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 543.72% | -56.38% | -96.64% | 68.51% | -127.86% |
| Cash from Investing | 522.95% | -55.87% | -97.23% | 78.09% | -129.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 165.06% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.69% | -112.63% | -268.08% | 14.75% | -223.68% |